The results of a trial on 59 patients with severe alopecia areata involving more than 30% of the scalp are reported. Topical 0.2% cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.
|Number of pages||6|
|Journal||Annali Italiani di Dermatologia Clinica e Sperimentale|
|Publication status||Published - 1988|
ASJC Scopus subject areas